TIMP2 and breast carcinoma: Relative expressions of TIMP2 mRNA in postoperatively surgical-resected FFPE tissues after neoadjuvant chemotherapy were lower than those in the paired needle biopsy tissues before treatment in breast cancer patients, which also testified that miR-4443 was targeted to TIMP2 in the pre-transcriptional association.